Evaluation of Drug-Induced QT Interval ProlongationImplications for Drug Approval and Labelling

被引：0
|
作者：
Marek Malik
A. John Camm
机构：
[1] St George’s Hospital Medical School,Department of Cardiological Sciences
来源：
Drug Safety | 2001年 / 24卷
关键词：
Moxifloxacin; Cisapride; Terfenadine; Cardiac Toxicity; Sparfloxacin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Assessment of proarrhythmic toxicity of newly developed drugs attracts significant attention from drug developers and regulatory agencies. Although no guidelines exist for such assessment, the present experience allows several key suggestions to be made and an appropriate technology to be proposed.
引用
收藏
页码：323 / 351
页数：28
相关论文
共 50 条
12345